Skip to content

Clinical trials

Completed Multiple Sclerosis, Relapsing-Remitting trials in Russia

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Multiple Sclerosis, Relapsing-Remitting Status: Completed Country / region: Russia Clear all

34 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20021
20031
20042
20062
20073
20083
20095
20105
20112
20122
20132
20152
20161
20171
20181
20191

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed34

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Biogen6
Genzyme, a Sanofi Company5
Novartis Pharmaceuticals5
Bayer2
Eli Lilly and Company2
GlaxoSmithKline2
Tanabe Pharma Corporation2
Apitope Technology (Bristol) Ltd.1
Biocad1
EMD Serono1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Multiple Sclerosis, Relapsing-Remitting34
Multiple Sclerosis19
Recurrence2
Demyelinating Diseases1
Diffuse Cerebral Sclerosis of Schilder1
Multiple Sclerosis, Chronic Progressive1
Neuromyelitis Optica1
Sclerosis1

Trials

Showing 1 to 25 of 34. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.